Desq Long
Sign in

Cluster

PHIO-2026-09-22-c3b386a88cd8

SEC FORM 4CLUSTER · 3 INSIDERS
$13,790.35

Phio Pharmaceuticals Corp. (PHIO)

Purchase of 13,500 shares across 3 reporting persons.

Transaction Code P · Reporting Persons 3

  • Bitterman Robert J, Chairman, Pres. & CEOPurchase of 2,000 shares at $1.0289 per share.$2,057.80
  • BRADFORD PATRICIA APurchase of 6,500 shares at $1.0127 per share.$6,582.55
  • Plott Ronald ToddPurchase of 5,000 shares at $1.03 per share.$5,150.00

Surfaced by rule: 3 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Sep 22, 2026 · Disclosed Sep 30, 2026FILED +8 DAYS

Source: SEC Form 4 · 0001683168-26-007321 · filed 2026-09-23 · View filing →

Source: SEC Form 4 · 0001683168-26-007432 · filed 2026-09-25 · View filing →

Source: SEC Form 4 · 0001683168-26-007499 · filed 2026-09-30 · View filing →

Permalink →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Phio Pharmaceuticals Corp. (PHIO)." Disclosed 2026-09-30. https://desqlong.com/cards/cluster-PHIO-2026-09-22-c3b386a88cd8 (retrieved 2026-10-01).